| Literature DB >> 25755997 |
Francesca Selmin1, Francesco Cilurzo1, Annalisa Aluigi2, Silvia Franzè1, Paola Minghetti1.
Abstract
This work aimed to develop membranes made of regenerated keratin and ceramides (CERs) to match the barrier property of the human stratum corneum in in vitro percutaneous absorption studies. The membrane composition was optimized on the basis of the in vitro drug diffusion profiles of ibuprofen, propranolol and testosterone chosen as model drugs on the basis of their different diffusion and solubility properties. The data were compared to those obtained using human epidermis. The ATR-FTIR and SEM analyses revealed that CERs were suspended into the regenerated keratin matrix, even if a partial solubilization occurred. It resulted in the membranes being physically stable after exposure to aqueous buffer and/or mineral oil and the fluxes of ibuprofen and propranolol from these vehicles through membranes and human skin were of the same order of magnitude. The best relationship with human epidermis data was obtained with 180 μm-thick membrane containing 1% ceramide III and 1% ceramide VI. The data on the testosterone diffusion were affected by the exposure of the membrane to a water/ethanol solution over a prolonged period of time, indicating that such an organic solvent was able to modify the supermolecular organization of keratin and CERs. The keratin/CER membranes can represent a simplified model to assay the in vitro skin permeability study of small molecules.Entities:
Keywords: Artificial membrane permeability assay; Ceramides; In vitro skin permeability; Regenerated keratin
Year: 2012 PMID: 25755997 PMCID: PMC4167178 DOI: 10.1016/j.rinphs.2012.10.001
Source DB: PubMed Journal: Results Pharma Sci ISSN: 2211-2863
Fluxes (μg x h/cm2) of ibuprofen (IB), propranolol (PR) and testosterone (TS) through keratin membranes at different compositions and thicknesses.
| Membrane | Components (%, w/w) | Thickness (μm) | Vehicle | IB | PR | TS | |||
|---|---|---|---|---|---|---|---|---|---|
| RK | CER3 | CER6 | Flux | FoD | Flux | Flux | |||
| 1 | 100 | – | – | 180 | Water | 9.26±0.04 | 2.51 | – | – |
| 2 | 99 | 1.0 | – | 180 | Water | 0.34±0.00 | 0.09 | – | – |
| 3 | 99 | – | 1.0 | 180 | Water | 1.20±0.34 | 0.32 | – | – |
| 4 | 99 | 0.5 | 0.5 | 180 | Water | 4.15±0.15 | 1.13 | – | – |
| 5 | 98 | 1.0 | 1.0 | 180 | Water | 2.97±0.12 | 0.80 | – | – |
| Physiologic solution | – | – | 10.0±1.0 | – | |||||
| Mineral oil | – | – | 8.7±3.0 | – | |||||
| Water/ethanol | – | – | – | 7.6±1.7 | |||||
| 140 | Water | 4.05±0.08 | 1.10 | – | – | ||||
| 60 | Water | 6.40±1.59 | 1.73 | – | – | ||||
| Human | Water | 3.69±1.69 | – | – | – | ||||
| epidermis | Physiologic solution | – | – | 17.9±4.3 | – | ||||
| Mineral oil | – | – | 17.2±5.9 | – | |||||
| Water/ethanol | – | – | – | 3.8±0.8 | |||||
n = 12, three donors (Cilurzo et al., 2010a)
n = 6, two donors.
Fig. 1SDS-PAGE; marker (line M), keratin powder (line 1), and keratin after casting from formic acid solutions (line 2).
Fig. 2Light microscopy (a) and scanning electron (b) micrographs of keratin membrane containing 1% w/w CER3 and 1% w/w CER6.
Fig. 3ATR-FTIR spectra of keratin membranes made of pure keratin (black line) and containing 1% w/w CER3 and 1% w/w CER6 (red line). The spectrum of human epidermis (blue line) is also reported, as reference. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Frequencies (cm−1) and assignments of deconvoluted amide I band for human skin and keratin membranes at different compositions.
| Assignment | Human epidermis | Membrane | ||||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | ||
| Hys-ring vibration | 1596 | 1594 | 1595 | 1595 | 1595 | 1595 |
| Ceramides | 1611 | – | 1612 | – | 1611 | 1611 |
| – | 1618 | – | 1618 | |||
| β-sheet intermolecular | 1620 | 1621 | 1623 | 1627 | 1628 | 1629 |
| β-sheet intramolecular | 1633 | 1632 | 1631 | 1631 | 1634 | 1635 |
| Random coil | 1644–1651 | 1645–1649 | 1644–1650 | 1643–1649 | 1644–1649 | 1642–1650 |
| α Helix | 1660 | 1660 | 1660 | 1658 | 1658 | 1658 |
| Turn | 1668 | 1668 | 1668 | 1668 | 1668 | 1668 |
| 1676 | 1674 | 1675 | 1674 | 1675 | 1674 | |
| 1681 | 1682 | 1681 | 1681 | 1681 | 1682 | |
| 1691 | 1695 | 1691 | 1691 | 1690 | 1694 | |
CER3: The peak is centred at 1613 cm−1.
CER6: The peak is centred at 1617 cm−1. Two shoulders are present at 1607 and 1632 cm−1.
CH stretching vibrations (cm−1) and assignments for raw ceramides, human skin and membranes at different compositions.
| Assignments | CER3 | CER6 | Human epidermis | Membrane | ||||
|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | ||||
| Asym CH3 | 2955 | 2956 | 2956 | 2957 | 2957 | 2957 | 2958 | 2959 |
| Asym CH2 | 2915 | 2915 | 2917 | 2923 | 2919 | 2920 | 2920 | 2923 |
| Sym CH3 | 2873 | 2874 | 2872 | 2872 | 2873 | 2873 | 2873 | 2873 |
| Sym CH2 | 2849 | 2849 | 2850 | 2855 | 2851 | 2851 | 2851 | 2853 |
Fig. 4IB permeation profile through keratin membrane containing 1% w/w CER3 and 1% w/w CER6 (solid line) with respect to human epidermis from three different donors (dashed line).
Fig. 5Permeation profiles of PR from (a) physiological solution and (b) mineral oil through keratin membrane containing 1% w/w CER3 and 1% w/w CER6 (solid line) with respect to human epidermis (dashed line).
Fig. 6TS permeation profile through keratin membrane containing 1% w/w CER3 and 1% w/w CER6 (solid line) with respect to human epidermis (dashed line).